从有限的医疗测试和药物数据进行因果推断的数据协作
Tomoru Nakayama1, Yuji Kawamata2, Akihiro Toyoda1
1Graduate School of Science and Technology, University of Tsukuba, Tsukuba, Japan.
Scientific reports
|March 22, 2025
概括
数据协作准实验 (DC-QE) 框架允许使用中间数据表示来进行保护隐私的因果推断. 这种方法增强了医疗保健研究,允许访问更大的数据集,同时保护患者的保密性.
科学领域:
- 医疗信息学 医疗信息学
- 生物统计学 生物统计学
- 流行病学 流行病学
背景情况:
- 随机对照试验 (RCT) 对于因果推断并不总是可行的.
- 跨机构整合敏感的医疗数据带来了重大的隐私挑战.
- 现有的方法通常需要共享原始患者数据,限制了合作研究.
研究的目的:
- 将数据协作准实验 (DC-QE) 框架应用于医疗数据.
- 在独立且相同分布 (IID) 和非IID条件下模拟分布式数据环境.
- 评估DC-QE在医疗保健中维护隐私的因果推理方面的有效性.
主要方法:
- 开发了一种在DC-QE框架内生成中间表示的方法.
- 将DC-QE应用于单个机构的医疗数据,以模拟分布式设置.
- 在IID和非IID条件下对个人和集中分析进行DC-QE性能比较.
主要成果:
- 在各个准确度指标中,DC-QE的表现始终优于个体分析.
- DC-QE性能与集中分析非常接近.
- 建议的中间表示方法提高了性能,特别是在非IID条件下.
结论:
- DC-QE框架提供了一种强大的方法,用于在医疗保健中维护隐私的因果推理.
- 使用中间表示方便访问更大,多样化的数据集,同时保持患者的保密性.
- 这种方法可以促进因果关系的发现,支持药物重新定位,并改善罕见疾病治疗方法.
相关概念视频
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
110
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
110
Causality in Epidemiology
220
Causality or causation is a fundamental concept in epidemiology, vital for understanding the relationships between various factors and health outcomes. Despite its importance, there's no single, universally accepted definition of causality within the discipline. Drawing from a systematic review, causality in epidemiology encompasses several definitions, including production, necessary and sufficient, sufficient-component, counterfactual, and probabilistic models. Each has its strengths and...
220
Hazard Ratio
72
The hazard ratio (HR) is a widely used measure in clinical trials to compare the risk of events, such as death or disease recurrence, between two groups over time. It reflects the ratio of hazard rates—the instantaneous risk of the event occurring—between a treatment group and a control group. This measure provides valuable insights into the relative effectiveness of a treatment by assessing how the risk of an event differs between the two groups.
For example, in a clinical trial...
For example, in a clinical trial...
72
Statistical Software for Data Analysis and Clinical Trials
471
Statistical software is pivotal in data analysis and clinical trials by providing tools to analyze data, draw conclusions, and make predictions. These software packages range from simple data management applications to complex analytical platforms, supporting various statistical tests, models, and simulation techniques. Their significance lies in their ability to handle vast amounts of data with precision and efficiency, enabling researchers to validate hypotheses, identify trends, and make...
471
Comparing the Survival Analysis of Two or More Groups
110
Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and...
110
Genome-wide Association Studies-GWAS
12.3K
Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
GWAS does not require the identification of the target gene involved in...
12.3K


